Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Functional Dyspepsia Clinical Trials

A listing of Functional Dyspepsia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (23) clinical trials

Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia

Multi-center, randomized, superiority, double blind clinical trial to asses the efficacy of fixed-dose combination of bromopride and simethicone versus isolated bromopride in the relief os dyspepsia symptoms on research participants diagnosed with functional dyspepsia.


Study of Motilitone to Treat Functional Dyspepsia

This study is to evaluate efficacy of the investigational drug Motilitone at 90 mg in patients with Functional Dyspepsia as measured by change in maximum tolerated volume and aggregate symptom score on the nutrient drink test.


Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

A phase , multi-center, randomized, double-blinded, placebo and active comparator clinical trial to assess the efficacy and safety of combination therapy of Motireb 5/100 mg in functional dyspepsia patients.


fMRI and Visceral Perception Upon Capsaicin Infusion

Brain imaging has shown abnormal brain activations in response to visceral stimulation in patients with the Irritable Bowel Syndrome (IBS). To investigate the possible role of the Nucleus of the Solitary Tract (NTS), the primary relay station in the brainstem for vagal afferents, its activation in IBS and functional dyspepsia ...

Phase N/A

SSRI Study for Functional Dyspepsia (SS)

Baseline assessment: Demographic: age, gender Anthropometric measurements: body mass index, height, weight and waist circumference FGI Screening Questionnaire (v.3, 20101011) for screening of functional gastrointestinal disorder according to Rome III criteria. Duration of dyspeptic symptoms will be recorded A combined Functional GI symptom Questionnaire (FGISQ) (version: FGISQ 20110504) based on ...


BRAVO Study for Functional Dyspepsia

Baseline assessment: All patients will be invited to complete self-administered questionnaires for demographics and baseline symptom assessment Demographics: age, gender Screening of functional gastrointestinal disorder based on the Rome III questionnaires Functional dyspepsia symptom questionnaire: an 8-item dyspeptic symptom score questionnaire using 4-point (0-3) Likert scale based on recall of ...


Effect of Genetic Association With Functional Dyspepsia and Mood Disorders

Methods All subjects will participate in (1) Demographic assessment, (2) Questionnaires administration and (3) Blood sample collection. The three steps must be completed within 2 weeks. Demographic assessment Demographic: age, gender Anthropometric measurements: body mass index, height, weight Smoke and drink habit Comorbidity and medical history Questionnaires administration A combined ...

Phase N/A

Tricyclic Antidepressants (TCAs) on Gastric Emptying

The normal control subjects will be randomized to receive either amitriptyline or desipramine as the tricyclic antidepressant agent, with 30 subjects per group. Subjects will undergo two outpatient gastric emptying/volume tests and two satiety tests; one of each after 7 days of treatment with oral consumption of the study agent ...

Phase N/A

Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients

This is a single-center study. The duration of this trial is estimated to be six months. A total of Forty (40) subjects will be recruited into this study. It will be two Groups; ten (10) normal healthy subjects will be recruited by poster advertisement and thirty (30) patients who either ...

Phase N/A

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.